The insider sales are too small to convey a material signal. Monitor for larger insider transactions or changes in guidance that could indicate management's view on the business trajectory.
ALKS drugs
ALKS drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Aug 4 $49.67entry
- T+1 · 3mo ago −0.12%α +0.08% · $49.61
- T+5 · 3mo ago −0.93%α −0.83% · $49.21
- T+20 · 3mo ago −4.97%α −3.73% · $47.20
- T+60 · 20d ago −10.77%α −11.15% · $44.32
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Two Alkermes executives (EVP CLO and EVP R&D/CMO) sold a combined $536K in open-market shares on August 3, 2026, one week after the company reported a Q2 EPS miss and widened GAAP net loss guidance. The sales are trivial relative to the $8.2B market cap (0.0065%) and likely represent routine post-earnings transactions rather than a bearish signal.
Key Financial Metrics
Key Facts
- EVP CLO David Gaffin sold 2,034 shares at $48.58 for ~$99K
- EVP R&D/CMO Craig Hopkinson sold 9,000 shares at $48.58 for ~$437K
- Total open-market sales of $536K represent 0.0065% of Alkermes' $8.2B market cap
- Sales occurred 7 days after Q2 2026 earnings miss (EPS $0.00 vs $0.29 consensus) and widened GAAP net loss guidance
Financial Impact
Total open-market sales of $536K represent 0.0065% of $8.2B market cap, immaterial.
Risk Factors
- Insider sales could accelerate if Q3 results disappoint further
- GAAP net loss guidance widening may pressure the stock if not offset by LUMRYZ revenue growth
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-ALKS-1785801678578 |
Track record
23 reports on ALKS
3 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +25.88% at T+60 after the May 12, 2026 report. 3 of 4 went positive at some point.
Filters
- Nov 12, 20264d ago 8-K Neutral 4/10 Entry $46.98 Now $46.53 −0.96% settles Feb 10
- Nov 4, 202612d ago Institutional Cluster Neutral 3/10 Entry $44.54 Now $46.53 +4.47% settles Feb 3
- Nov 3, 202613d ago 144 Neutral 2/10 Entry $45.89 Now $46.53 +1.39% settles Feb 2
- Nov 3, 202613d ago 8-K Neutral 5/10 Entry $45.69 Now $46.53 +1.84% settles Feb 1
- Sep 21, 20268w ago 8-K Bullish 6/10 Entry $44.00 Now $46.53 +5.76% settles Dec 15
- Sep 16, 20268w ago 8-K Neutral 2/10 Entry $46.07 Now $46.53 +1.00% settles Dec 10
- Sep 3, 202610w ago Insider Cluster Neutral 2/10 Entry $46.10 Now $46.53 +0.93% settles Dec 1
- Aug 3, 202615w ago Insider Cluster Bearish 4/10 Entry $49.67 to $44.32 Now $46.53 +6.32% ▲ +10.77% +11.15% vs SPY
- Aug 3, 202615w ago Insider Cluster Neutral 2/10 Viewing Entry $49.67 to $44.32 Now $46.53 −6.32% ▼ −10.77% −11.15% vs SPY
- Aug 3, 202615w ago Insider Cluster Neutral 3/10 Entry $49.67 to $44.32 Now $46.53 −6.32% ▼ −10.77% −11.15% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers